Blue Therapeutics announces Series A raise
- Friday, April 30, 2021, 7:14
- Environment
- Add a comment
WALTHAM, Mass., April 30, 2021 /PRNewswire/ — Blue Therapeutics is a Boston based drug discovery and development company. The lead asset BLUE-181 is approaching IND and has successfully provided the proof of concept and the blueprint for the R2i platform. Based on the concept of…
About the Author
adminasapcorp has written 38936 stories on this site.